2024-512164-63-00尚未招募1/2 期
New therapeutic approach to Toxic Epidermal Necrolysis (TEN) using anti-CD38+ antibodies in the active phase of the disease – Phase I/II study to assess the tolerance and efficacy of DARATUMUMAB - NET-CD38 Study
适应症
试验速览
- 阶段
- 1/2 期
- 状态
- 尚未招募
- 入组人数
- 9
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr Benoit BEN SAID
Scientific
Hospices Civils De Lyon
研究点 (1)
Loading locations...
相似试验
终止
1 期
Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal NecrolysisStevens-Johnson SyndromeToxic Epidermal NecrolysisNCT02037347Brett King1
招募中
不适用
A new treatment for skin ulcers associated with systemic sclerosis using the ability of own bone marrow cells to regenerate blood vessels (TASSCAT-BM-MNC)Systemic sclerosisjRCTb03221020412
进行中（未招募）
不适用
Behandling av premaligna hudlesioner med topikal imiquimod och fotodynamisk terapi hos organtransplanterade patienter en randomiserad intraindividuell studie med blindad effekt utvärderingEUCTR2008-004044-36-SEBispebjerg Hospital35
进行中（未招募）
1 期
Behandling af præmaligne hudlæsioner med topikal imiquimod og fotodynamisk terapi hos organtransplanterede patienter - et randomiseret intraindividuelt forsøg med blindet effektvurderingAktiniske keratoser og virale vorterMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisMedDRA version: 9.1Level: LLTClassification code 10047829Term: Warts (viral)EUCTR2008-004044-36-DKBispebjerg Hospital35
尚未招募
1 期
A new drug as an adjunct therapy for patients of dry eye diseaseCTRI/2024/04/065924Dr RP Centre Of Ophthalmic Sciences